Vivakor, Inc. — Form 8-K Summary
Reporting context: The report concerns an unregistered issuance of common stock upon conversion of convertible promissory notes. It is dated November 12, 2026, and signed November 18, 2026. The conversions and share issuances occurred November 12–13, 2026.
Key transaction details
- Vivakor previously issued notes with aggregate principal of $15 million to two non-affiliated accredited investors under a May 7, 2026 securities purchase agreement. The company received a first tranche of $6 million on May 8, 2026.
- Investors converted $729,848 of principal and interest into 3,170,000 shares of common stock.
- The shares were issued without a Rule 144 restrictive legend, based on a legal opinion received by the company and its transfer agent. The company states the issuance was exempt from registration under Securities Act Section 4(a)(2).
Financial performance and changes
This 8-K does not report revenue, profit, cash flow, margins, debt balances, liquidity, or other operating results. It does not provide a clear remaining balance under the notes or a conversion price. No comparable-period financial results are presented.
Outlook, risks, and contingencies
The filing contains general forward-looking-statement cautions: future plans and objectives are subject to risks and uncertainties, actual results may differ materially, and the company disclaims an obligation to update statements except as required by law. No specific business guidance or transaction contingency is disclosed.
Important facts for investors to verify
- The notes’ current outstanding principal and interest, including any remaining commitment or undrawn tranches.
- The conversion-price calculation and the resulting ownership dilution from the 3,170,000 shares.
- The legal basis for issuing the shares without a restrictive legend and the availability of the shares for resale.
- Any subsequent note conversions, payments, or amendments not described in this filing.